The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / October / Earwax Lipids Offer Clues to Ménières
Biochemistry and molecular biology Analytical science Technology and innovation

Earwax Lipids Offer Clues to Ménière’s

The experimental method combines rapid chemical profiling with targeted fatty acid measurement

10/09/2026 News 2 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll

Share

5 Key Takeaways
  • 1

    A 2023 pilot study examined whether earwax chemical patterns could distinguish people with Ménière’s disease from those without it.

  • 2

    Three fatty acids were detected in both groups, but their concentrations were lower in samples from patients with Ménière’s disease.

  • 3

    Average concentrations of cis-9-hexadecenoic, cis-10-heptadecenoic, and cis-9-octadecenoic acids were approximately 78%, 85%, and 58% lower, respectively.

  • 4

    The classification model correctly categorized 3 additional samples, but its internal performance was modest and the small test set cannot establish diagnostic accuracy.

  • 5

    The mass spectrometry-based approach remains at an early laboratory stage and requires larger prospective studies before its diagnostic performance can be determined.

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Your Privacy Choices
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.